| 000 | 01909 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517003030.0 | ||
| 264 | 0 | _c20160323 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1865-8652 | ||
| 024 | 7 |
_a10.1007/s12325-014-0166-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnston, Stephen S | |
| 245 | 0 | 0 |
_aRetrospective study of adherence to glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus in the United States. _h[electronic resource] |
| 260 |
_bAdvances in therapy _cNov 2014 |
||
| 300 |
_a1119-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aExenatide |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xanalogs & derivatives |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide-1 Receptor _xmetabolism |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLiraglutide _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 |
_aPeptides _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aVenoms _xadministration & dosage |
| 650 | 0 | 4 | _aAssessment of Medication Adherence |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor Agonists |
| 700 | 1 | _aNguyen, Hiep | |
| 700 | 1 | _aFelber, Eugene | |
| 700 | 1 | _aCappell, Katherine | |
| 700 | 1 | _aNelson, James K | |
| 700 | 1 | _aChu, Bong-Chul | |
| 700 | 1 | _aKalsekar, Iftekhar | |
| 773 | 0 |
_tAdvances in therapy _gvol. 31 _gno. 11 _gp. 1119-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12325-014-0166-0 _zAvailable from publisher's website |
| 999 |
_c24364767 _d24364767 |
||